{"schema_version":"secwatch.filing_event.v1","accession":"0001842952-21-000005","form_type":"8-K","ticker":"CNTX","cik":"0001842952","company_name":"Context Therapeutics Inc.","filed_at":"2021-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.653744+00:00","generated_at":"2026-06-28T15:52:54.225926+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Context Therapeutics appoints Jennifer Minai-Azary as CFO with $365K base salary","bullets":["Jennifer Minai-Azary appointed CFO; previously CFO at Millendo Therapeutics, led merger with Tempest.","Employment agreement: $365,000 annual base salary; target annual bonus of 40% of base salary.","Granted non-qualified stock options for 52,753 shares, vesting monthly over 3 years.","Severance: 9 months base salary if terminated without cause; change-in-control triggers 12 months salary plus full equity vesting.","Press release also notes Alex Levit was appointed Chief Legal Officer in April 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001842952-21-000005","json":"https://secwatch.observer/filing/0001842952-21-000005.json","markdown":"https://secwatch.observer/filing/0001842952-21-000005.md","text":"https://secwatch.observer/filing/0001842952-21-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842952/000184295221000005/0001842952-21-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842952/000184295221000005/cntx-20211101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T15:52:54.225926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c7b1b13135","claim":"Jennifer Minai-Azary was appointed as Chief Financial Officer at Context Therapeutics Inc..","evidence_excerpt":"On November 1, 2021, Context Therapeutics Inc. (the “Company”) appointed Jennifer Minai-Azary as the Company’s Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842952/000184295221000005/0001842952-21-000005-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}